Antiangiogenic therapy for hepatacellular carcinoma: Metformin, the widely used drug to treat NIDDM, inhibits the progression of hepatocellular carcinoma through suppression of the oncogenic HGF-c-Met pathway, 14/July/2014, 5.01 am

Gastric carcinoma therapy: Tumor suppressor p63 suppresses the expression of inflammation–induced IL-23A in Gastric epithelial cells, 14/July/2014, 4.58 am
July 13, 2014
Anti-miRNA based treatment for Globozoospermia: miRNA-375 regulates acrosome biogenesis during spermatogenesis via down regulation of its target gene, 14/July/2014, 5.15 am
July 13, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan PhD

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Antiangiogenic therapy for hepatacellular carcinoma: Metformin, the widely used drug to treat NIDDM, inhibits the progression of hepatocellular carcinoma through suppression of the oncogenic HGF-c-Met pathway, 14/July/2014, 5.01 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.